Ir para o conteúdo principal

Tema Cardiovascular and Metabolic ETF (NYSE: HRTS) — Perfil da empresa, notícias e dados financeiros

Logo de Tema Cardiovascular and Metabolic ETF
HRTS Tema Cardiovascular and Metabolic ETF
Tema Cardiovascular and Metabolic ETF primary media
Perfil da empresa

Tema Cardiovascular and Metabolic ETF

Sobre

Explorar empresas de United States

Tema Obesity & Cardiometabolic ETF (NASDAQ:HRTS) is an exchange-traded fund (ETF) that invests in companies focused on developing solutions for obesity and cardiometabolic diseases. Launched in November 2023, HRTS tracks firms involved in weight-loss drugs, diabetes treatments, and other related areas. The fund offers exposure to this growing market with a relatively low expense ratio of 0.75%. It started trading around $26 per share and currently sits at $32, with over $61 million in assets under management.

Resumo

Public USParticipação acionária
2023Ano de fundação
18Funcionários
New York, United StatesSede
Carregando mapa...
Presença global

Operações

Todos os locais
New York City, US

Produtos e/ou serviços de Tema Cardiovascular and Metabolic ETF

  • Investing in companies pioneering cardiovascular treatments.
  • Funding metabolic disorder research initiatives.
  • Supporting technologies for non-invasive cardiovascular diagnostics.
  • Promoting advanced therapies for heart failure management.
  • Backing innovations in lipid management solutions.
  • Endorsing new approaches to obesity treatment development.